Literature DB >> 15363637

Carnitine acyltransferases and their influence on CoA pools in health and disease.

Rona R Ramsay1, Victor A Zammit.   

Abstract

Cells contain limited and sequestered pools of Coenzyme A (CoA) that are essential for activating carboxylate metabolites. Some acyl-CoA esters have high metabolic and signalling impact, so control of CoA ester concentrations is important. This and transfer of the activated acyl moieties between cell compartments without wasting energy on futile cycles of hydrolysis and resynthesis is achieved through the carnitine system. The location, properties of and deficiencies in the carnitine acyltransferases are described in relation to their influence on the CoA pools in the cell and, hence, on metabolism. The protection of free CoA pools in disease states is achieved by excretion of acyl-carnitine so that carnitine supplementation is required where unwanted acyl groups build up, such as in some inherited disorders of fatty acid oxidation. Acetyl-carnitine improves cognition in the brain and propionyl-carnitine improves cardiac performance in heart disease and diabetes. The therapeutic effects of carnitine and its esters are discussed in relation to the integrative influence of the carnitine system across CoA pools. Recent evidence for sequestered pools of activated acetate for synthesis of malonyl-CoA, for the synthesis of polyunsaturated fatty acids and for the inhibition of carnitine palmitoyltransferase 1 to regulate fatty acid oxidation is reviewed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363637     DOI: 10.1016/j.mam.2004.06.002

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  49 in total

1.  Decreased expression of adipose CD36 and FATP1 are associated with increased plasma non-esterified fatty acids during prolonged fasting in northern elephant seal pups (Mirounga angustirostris).

Authors:  Jose Abraham Viscarra; José Pablo Vázquez-Medina; Ruben Rodriguez; Cory D Champagne; Sean H Adams; Daniel E Crocker; Rudy M Ortiz
Journal:  J Exp Biol       Date:  2012-07-15       Impact factor: 3.312

2.  Evidence of a preferred kinetic pathway in the carnitine acetyltransferase reaction.

Authors:  Michael J Kratochvil; Nick K Balerud; Samantha J Schindler; Michael A Moxley
Journal:  Arch Biochem Biophys       Date:  2020-07-22       Impact factor: 4.013

3.  CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability.

Authors:  Gerritje J W van der Windt; David O'Sullivan; Bart Everts; Stanley Ching-Cheng Huang; Michael D Buck; Jonathan D Curtis; Chih-Hao Chang; Amber M Smith; Teresa Ai; Brandon Faubert; Russell G Jones; Edward J Pearce; Erika L Pearce
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

4.  Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease.

Authors:  Nadav I Weinstock; Lawrence Wrabetz; M Laura Feltri; Daesung Shin
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

5.  Crystal structures of murine carnitine acetyltransferase in ternary complexes with its substrates.

Authors:  Yu-Shan Hsiao; Gerwald Jogl; Liang Tong
Journal:  J Biol Chem       Date:  2006-07-26       Impact factor: 5.157

6.  Dynamic monitoring of carnitine and acetylcarnitine in the trimethylamine signal after exercise in human skeletal muscle by 7T 1H-MRS.

Authors:  Jimin Ren; Susan Lakoski; Ronald G Haller; A Dean Sherry; Craig R Malloy
Journal:  Magn Reson Med       Date:  2012-04-03       Impact factor: 4.668

7.  Altered Carnitine Homeostasis in Children With Increased Pulmonary Blood Flow Due to Ventricular Septal Defects.

Authors:  Stephen M Black; Aida Field-Ridley; Shruti Sharma; Sanjiv Kumar; Roberta L Keller; Rebecca Kameny; Emin Maltepe; Sanjeev A Datar; Jeffrey R Fineman
Journal:  Pediatr Crit Care Med       Date:  2017-10       Impact factor: 3.624

8.  Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock.

Authors:  Deborah M Muoio
Journal:  Cell       Date:  2014-12-04       Impact factor: 41.582

9.  Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation.

Authors:  Rainer Lehmann; Xinjie Zhao; Cora Weigert; Perikles Simon; Elvira Fehrenbach; Jens Fritsche; Jürgen Machann; Fritz Schick; Jiangshan Wang; Miriam Hoene; Erwin D Schleicher; Hans-Ulrich Häring; Guowang Xu; Andreas M Niess
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

Review 10.  Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.

Authors:  Carmen Mingorance; Rosalía Rodríguez-Rodríguez; María Luisa Justo; María Alvarez de Sotomayor; María Dolores Herrera
Journal:  Vasc Health Risk Manag       Date:  2011-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.